Cargando…
Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study
Global health is under heavy threat by a worldwide pandemic caused by a new type of coronavirus (COVID-19) since its rapid spread in China in 2019 [1]. Currently, there are no approved specific drugs and effective treatment for COVID-19 infection, but several available drugs are known to facilitate...
Autores principales: | Bolelli, Kayhan, Ertan-Bolelli, Tugba, Unsalan, Ozan, Altunayar-Unsalan, Cisem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550866/ https://www.ncbi.nlm.nih.gov/pubmed/33071354 http://dx.doi.org/10.1016/j.molstruc.2020.129449 |
Ejemplares similares
-
Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin
por: Ertan-Bolelli, Tugba, et al.
Publicado: (2022) -
Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
por: Alzamami, Ahmad, et al.
Publicado: (2022) -
Digital system design with FPGA: implementation using Verilog and VHDL
por: Unsalan, Cem, et al.
Publicado: (2017) -
4-Thiazolidinone Derivatives as MMP Inhibitors in Tissue Damage: Synthesis, Biological Evaluation and Docking Studies
por: Incerti, Matteo, et al.
Publicado: (2018) -
Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
por: Jiménez-Alberto, Alicia, et al.
Publicado: (2020)